These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38687317)

  • 1. Monkeypox: A re-emerging disease.
    Kaur N; Dabar J; Bassi P
    Indian J Pharmacol; 2024 Mar; 56(2):129-135. PubMed ID: 38687317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment and Vaccination for Smallpox and Monkeypox.
    Saalbach KP
    Adv Exp Med Biol; 2024; 1451():301-316. PubMed ID: 38801586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanded Access Programme for the use of tecovirimat for the treatment of monkeypox infection: A study protocol for an Expanded Access Programme.
    Bourner J; Redji Mbrenga FD; Malaka CN; Dunning J; Rojek A; Fandema E; Horby P; Boum Y; Nakouné E; Olliaro P
    PLoS One; 2024; 19(5):e0278957. PubMed ID: 38722986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monkeypox Virus (MPXV) Infection: A Review.
    Kumari R; Arya P; Yadav SP; Mishra RC; Yadav JP
    Infect Disord Drug Targets; 2024; 24(4):76-82. PubMed ID: 38243966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and Efficacy of a Potential Smallpox Therapeutic, Brincidofovir, in a Lethal Monkeypox Virus Animal Model.
    Hutson CL; Kondas AV; Mauldin MR; Doty JB; Grossi IM; Morgan CN; Ostergaard SD; Hughes CM; Nakazawa Y; Kling C; Martin BE; Ellison JA; Carroll DS; Gallardo-Romero NF; Olson VA
    mSphere; 2021 Feb; 6(1):. PubMed ID: 33536322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with the smallpox antiviral tecovirimat (ST-246) alone or in combination with ACAM2000 vaccination is effective as a postsymptomatic therapy for monkeypox virus infection.
    Berhanu A; Prigge JT; Silvera PM; Honeychurch KM; Hruby DE; Grosenbach DW
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4296-300. PubMed ID: 25896687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tecovirimat is effective against human monkeypox virus in vitro at nanomolar concentrations.
    Frenois-Veyrat G; Gallardo F; Gorgé O; Marcheteau E; Ferraris O; Baidaliuk A; Favier AL; Enfroy C; Holy X; Lourenco J; Khoury R; Nolent F; Grosenbach DW; Hruby DE; Ferrier A; Iseni F; Simon-Loriere E; Tournier JN
    Nat Microbiol; 2022 Dec; 7(12):1951-1955. PubMed ID: 36344621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mouse model of lethal infection for evaluating prophylactics and therapeutics against Monkeypox virus.
    Stabenow J; Buller RM; Schriewer J; West C; Sagartz JE; Parker S
    J Virol; 2010 Apr; 84(8):3909-20. PubMed ID: 20130052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human monkeypox virus infection in an immunocompromised man: trial with tecovirimat.
    Hernandez LE; Jadoo A; Kirsner RS
    Lancet; 2022 Sep; 400(10355):e8. PubMed ID: 36088950
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical considerations on monkeypox antiviral medications: An overview.
    Pourkarim F; Entezari-Maleki T
    Pharmacol Res Perspect; 2024 Feb; 12(1):e01164. PubMed ID: 38149674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mini Review on Clinical Aspects of Monkeypox.
    Saraswat Y; Shah K
    Curr Pharm Biotechnol; 2024; 25(4):411-425. PubMed ID: 37711132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tecovirimat and the Treatment of Monkeypox - Past, Present, and Future Considerations.
    Sherwat A; Brooks JT; Birnkrant D; Kim P
    N Engl J Med; 2022 Aug; 387(7):579-581. PubMed ID: 35921403
    [No Abstract]   [Full Text] [Related]  

  • 13. Monkeypox Outbreak 2022, from a Rare Disease to Global Health Emergence: Implications for Travellers.
    Adegboye O; Alele F; Pak A; Alakunle E; Emeto T; Leggat P; Okeke M
    Adv Exp Med Biol; 2024; 1451():355-368. PubMed ID: 38801590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compassionate Use of Tecovirimat for the Treatment of Monkeypox Infection.
    Desai AN; Thompson GR; Neumeister SM; Arutyunova AM; Trigg K; Cohen SH
    JAMA; 2022 Oct; 328(13):1348-1350. PubMed ID: 35994281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Brincidofovir in Preparation for a Potential Smallpox Outbreak.
    Foster SA; Parker S; Lanier R
    Viruses; 2017 Oct; 9(11):. PubMed ID: 29773767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential use of cidofovir, brincidofovir, and tecovirimat drugs in fighting monkeypox infection: recent trends and advancements.
    Rani I; Joshi H; Sharma U; Kaur J; Sood S; Ramniwas S; Chauhan A; Abdulabbas HS; Tuli HS
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Apr; 397(4):2055-2065. PubMed ID: 37837475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Perspectives on Antimicrobial Agents: Tecovirimat for Treatment of Human Monkeypox Virus.
    DeLaurentis CE; Kiser J; Zucker J
    Antimicrob Agents Chemother; 2022 Dec; 66(12):e0122622. PubMed ID: 36374026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Advances in the Prevention and Management of Monkeypox Viral Infection in Humans.
    Gujjar P; Chaudhay R; Verma I; Bansal N; Gupta S; Bansal S
    Curr Drug Targets; 2023; 24(13):1032-1045. PubMed ID: 37842888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The successful treatment of mpox with brincidofovir in renal transplant recipients-a report of 2 cases.
    Alameer RM; Yamani A; Al-Saud A; Alsobayeg S; Alamro B; Alali A; Hammad E; Shendi AM; Almaghrabi RS
    Int J Infect Dis; 2024 Jun; 143():107015. PubMed ID: 38521447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Virology of Orthopoxviruses with Special Reference to Monkeypox Virus.
    Rohaim MA; Naggar RFE; Atasoy MO; Munir M
    Adv Exp Med Biol; 2024; 1451():111-124. PubMed ID: 38801574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.